“Noninfectious” Cutaneous Granulomas in Primary Immunodeficiency Patients and Association With Rubella Virus Vaccine Strain

Abstract

Get full access to this article

View all access options for this article.

References

Shoimer

Wright

Haber

. Noninfectious granulomas: a sign of an underlying immunodeficiency? J Cutan Med Surg. 2016;20(3):259-262. doi:10.1177/1203475415626085.

Bodemer

Auvage

Mahlaoui

et al. Live rubella virus vaccine long-term persistence as an antigenic trigger of cutaneous granulomas in patients with primary immunodeficiency. Clin Microbiol Infect. 2014;20(10):O656-O663. doi:10.1111/1469-0691.12573.

Perelygina

Plotkin

Russo

. Rubella persistence in epidermal keratinocytes and granuloma M2 macrophages in patients with primary immunodeficiencies. J Allergy Clin Immunol. 2016;138(5):1436-1439. doi:10.1016/j.jaci.2016.06.030.

Neven

Pérot

Bruneau

et al. Cutaneous and visceral chronic granulomatous disease triggered by a rubella virus vaccine strain in children with primary immunodeficiencies. Clin Infect Dis. 2017;64(1):83-86. doi:10.1093/cid/ciw675.

Perelygina

Hautala

Seppänen

Adebayo

Sullivan

Icenogle

. Inhibition of rubella virus replication by the broad-spectrum drug nitazoxanide in cell culture and in a patient with a primary immune deficiency. Antiviral Res. 2017;147:58-66. doi:10.1016/j.antiviral.2017.09.019.